 adjuv therapi node-neg breast cancer use prognost factor patient patient invas breast cancer neg lymph node NO favor surviv rate small cm primari tumor overal recurr local therapi adjuv chemotherapi tamoxifen disease-fre surviv df overal surviv OS unansw question optim end point df OS risk mani clinician prognost indic treatment recommend avail accur inform tnm patholog featur hormon receptor ploidi s-phase fraction amplif over-express cathepsin-d use prognost indic precis system sever prognost variabl decis adjuv system therapi good prognosi group patient physician whenev possibl patient clinic trial